Introduction
============

*Streptomyces pristinaespiralis* produces the streptogramin‐type antibiotic pristinamycin. Like other members of this family (also designated synergimycins), such as virginiamycin, mikamycin, vernamycin and others ([@b13]), pristinamycin is a mixture of two different chemical classes of components, pristinamycin I (PI) and pristinamycin II (PII). PI is a branched cyclic hexadepsipeptide of the B group of streptogramins, while pristinamycin PII has the structure of a polyunsaturated cyclo‐peptidic macrolactone belonging to the A group of streptogramins ([Figs 3A](#f3){ref-type="fig"} and [5](#f5){ref-type="fig"}). PI and PII are produced as different congeners. PI~A~ is the major form of PI (usually 90--95%) containing a 4‐*N*,*N*‐dimethylamino‐[l]{.smallcaps}‐phenylalanine (DMAPA) residue instead of *N*‐methyl‐4‐(methylamino)‐[l]{.smallcaps}‐phenylalanine (MMAPA) in the PI~B~ minor form (5%) ([@b10]). The PII component is synthesized mainly in two forms, PII~A~ and PII~B~, which are present in an 80:20 ratio. The difference between PII~A~ and PII~B~ is the presence of a dehydroproline instead of a [d]{.smallcaps}‐proline in the macrocycle respectively ([@b8]).

![Schematic presentation of the PII biosynthetic pathway in *S. pristinaespiralis*. A. Domain arrangement of the PII biosynthetic enzymes. PKS domains: AT, acyl transferase; ACP, acyl carrier protein; KS, β‐ketoacyl‐ACP synthase; DH, dehydrogenase; KR, ketoreductase; MT, methyltransferase; TE, thioesterase. NRPS domains: A, adenylation; C, condensation; P, peptidyl carrier protein; BCDH, branched‐chain α‐keto acid dehydrogenase complex; HCS, hydroxymethylglutaryl‐CoA (HMG‐CoA) synthase; ECH, enoyl‐CoA hydratase; unk, unknown. B. HMG‐based model for the incorporation of the C12 methyl group in PII. G, SnaG; E2, ACP of SnaE2.](mbt0004-0192-f3){#f3}

![Schematic presentation of the PI biosynthetic pathway in *S. pristinaespiralis*. Domain arrangement of the PI NRPSs SnbA, SnbC and SnbDE. Domains: A, adenylation; C, condensation; P, peptidyl carrier protein; M, methyltransferase; T, thioesterase. Amino acids: L‐HPA, [l]{.smallcaps}‐hydroxypicolinic acid; L‐Thr, [l]{.smallcaps}‐threonine; L‐Aba, [l]{.smallcaps}‐aminobutyric acid; L‐Pro, [l]{.smallcaps}‐proline; DMAPA, 4‐*N,N*‐dimethylamino‐[l]{.smallcaps}‐phenylalanine; L‐Pip, 4‐oxo‐[l]{.smallcaps}‐pipecolic acid; L‐Phe, [l]{.smallcaps}‐phenylglycine. *R* = CH~3~ (PI~A~), *R* = H (PI~B~).](mbt0004-0192-f5){#f5}

Pristinamycin I and pristinamycin II are coproduced by *S. pristinaespiralis* in a ratio of 30:70. Each compound binds to the bacterial 50 S ribosomal subunit and inhibits the elongation process of the protein synthesis, thereby exhibiting only a moderate bacteriostatic activity. However, the combination of both substances acts synergistically and leads to a potent bactericidal activity that can reach up to 100 times that of the separate components ([@b37]). Pristinamycin is very active against a broad range of Gram‐positive bacteria, including methicillin‐resistant staphylococci, drug‐resistant *Streptococcus pneumoniae* and vancomycin‐resistant *Enterococcus faecium* as well as against some Gram‐negative bacteria, such as *Haemophilus* spp. Due to its antimicrobial capacities, pristinamycin is used as a therapeutic drug in human medicine, such as the semi‐synthetic streptogramin Synercid, which is a mixture of the PI derivative quinupristin and the PII derivative dalfopristin ([@b5]).

Pristinamycin I is synthesized by non‐ribosomal peptide synthetases (NRPSs) that catalyse the stepwise condensation of seven amino acid precursors: 3‐hydroxypicolinic acid, [l]{.smallcaps}‐threonine, [l]{.smallcaps}‐aminobutyric acid, [l]{.smallcaps}‐proline, DMAPA, 4‐oxo‐[l]{.smallcaps}‐pipecolic acid and [l]{.smallcaps}‐phenylglycine ([@b14]). PII is suggested to be synthesized from isobutyryl‐CoA as a starter unit. Six malonyl‐CoA extender units and the amino acids glycine, serine and proline are subsequently added by the action of hybrid PKS/NRPS enzymes ([@b42]).

Only partial sequence information of the pristinamycin biosynthetic gene cluster has been previously reported, and only a few of the biosynthetic genes have been characterized ([@b7]; [@b4]). In previous studies, the cluster organization was elucidated by pulsed‐field gel electrophoresis and was mapped to four non‐overlapping chromosomal regions A, B, C and D ([@b4]). Region B, C and D together harbour some of the pristinamycin structural genes and thus represent the antibiotic biosynthetic gene cluster ([Fig. 1](#f1){ref-type="fig"}). Thereby, the PI and PII structural genes exhibit a unique organization because they are not arranged in discrete clusters but are more or less mixed among each other. Region A encompasses a pristinamycin resistance gene *ptr* that is located outside the biosynthetic cluster ([@b4]). Due to its interspersed organization, we do not name this region a 'cluster' but rather the 'pristinamycin biosynthetic gene region'.

![Schematic presentation of the primordial pristinamycin biosynthetic gene region. Gaps are shown as spaces. Cosmids pYJM1‐5 are indicated by broken lines. The fragments, amplified by PCR and used as probes in the screening approach, are demonstrated as diagonal boxes and denoted by the prefix *frg*.](mbt0004-0192-f1){#f1}

So far, the overall organization of the pristinamycin biosynthetic gene region and its boundaries has not yet been described. Furthermore, the published sequence contains large gaps and several genes known to be essential for PI and PII biosynthesis have not been identified.

In this study, we report on the characterization of the complete pristinamycin biosynthetic gene region and the identification of a cryptic type II PKS gene cluster in *S. pristinaespiralis* Pr11. This provides information on the origin and the unique gene organization of the 'pristinamycin supercluster' and on pristinamycin biosynthesis.

Results and discussion
======================

Isolation and characterization of DNA fragments covering the gaps and borders of the pristinamycin biosynthetic gene region
---------------------------------------------------------------------------------------------------------------------------

Thus far, only parts of the pristinamycin biosynthetic gene cluster have been isolated and characterized, and only 16 genes have been described to be involved in pristinamycin biosynthesis ([Fig. 1](#f1){ref-type="fig"}) ([@b7]; [@b4]). To complete the pristinamycin biosynthetic gene region, a *S. pristinaespiralis* Pr11 cosmid library was constructed and used in hybridization experiments to search for cosmids that overlap with published sequences. The cosmids were analysed by restriction analyses, polymerase chain reaction (PCR) and Southern blotting experiments to select overlapping cosmids (see *Experimental procedures*). After sequencing the cosmids, the obtained sequence data were assembled to contigs and were analysed *in silico*.

Small gaps (\< 10 kb) within regions B, C and D were closed by sequencing of PCR products spanning these gaps. To close the large gaps in between region B, C and D, DNA probes were derived from the inner cluster borders and used for screening approaches with the *S. pristinaespiralis* cosmid library ([Fig. 1](#f1){ref-type="fig"}). Three cosmids were chosen to be sequenced covering the large gaps within the pristinamycin gene region: cosmid pYJM3 and pYJM4 span the gap between regions B and C, whereas pYJM5 covers the gap between regions C and D ([Fig. 1](#f1){ref-type="fig"}). To find the boundaries of the pristinamycin biosynthetic gene region, probes from the 5′ (left border) and 3′ (right border) ends of the known sequence were designed, where the genes *samS* and *snbR* are localized respectively. Cosmid pYJM1 and pYJM2 were identified and sequenced, which overlap with the left and right boundaries of the gene region respectively ([Fig. 1](#f1){ref-type="fig"}).

The sequence data were assembled to contigs. Still existing gaps were closed using the *S. pristinaespiralis* ATCC 25486 draft sequence data as a scaffold to align the *S. pristinaespiralis* Pr11 sequence. The genome of *S. pristinaespiralis* ATCC 25486 is sequenced in part (Accession No. ABJI00000000; M. Fischbach, P. Godfrey, D. Ward, S. Young, Q. Zeng, M. Koehrsen *et al*., unpublished) and preliminary sequence data are accessible in GenBank. In this way it was possible to obtain one scaffold containing three contigs, of which 210 kb constitute the pristinamycin biosynthetic gene region ([Fig. 2](#f2){ref-type="fig"}).

![Schematic presentation of the pristinamycin biosynthetic gene region of *S. pristinaespiralis* Pr11. PI and PII biosynthetic genes are shown as red and blue arrows respectively. Genes for regulation, resistance and of general function are shown as black arrows. Genes of unknown function are shown as grey arrows. The ∼ 90 kb interjacent gene region is shown as a dashed line. Parallel dashes mark the gene region boundaries.](mbt0004-0192-f2){#f2}

Taking the initial *S. pristinaespiralis* genome size of 7500 kb as predicted by [@b4]), the cluster corresponds to 2.8% of the whole linear chromosome. Forty‐five genes covering a region of ∼ 120 kb were assigned as pristinamycin‐specific genes involved in the biosynthesis, regulation and resistance of pristinamycin, and 32 genes covering a region of ∼ 40 kb presumably code for the biosynthesis of a type II aromatic polyketide. The function of the remaining ∼ 50 kb, mainly located within the ∼ 90 kb interjacent sequence region, is unknown (see below; [Figs 2](#f2){ref-type="fig"} and [6](#f6){ref-type="fig"}, [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}). Altogether, this makes the pristinamycin biosynthetic gene region the largest antibiotic 'supercluster' that has been described so far.

![Production profiles of *S. pristinaespiralis* Pr11 wild‐type (left) and mutant M*cpp8* (right) respectively. Pristinamycin PI~A~ (*R*~t~ = 7.5 min), PII~A~ (*R*~t~ = 8.3 min) and PII~B~ (*R*~t~ = 7.7 min) were detected by UV‐Vis spectrometry (data not shown). Corresponding UV‐VIS spectra of retention region 7.5--7.7 are listed below. Multiple wavelength monitoring was performed at 210 (black), 230 (red), 260 (blue), 280 (green), 310 (light blue), 360 (magenta) and 435 (yellow) nm.](mbt0004-0192-f6){#f6}
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Pristinamycin‐related genes and their deduced functions.
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###### 

Schematic presentation of the *S. pristinaespiralis* Pr11 *cpp* cluster with a size of approximately 40 kb encoding the unknown substance.
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Definition of the gene cluster boundaries
-----------------------------------------

The left boundary of the pristinamycin gene cluster was previously defined by the gene *samS*, which is localized adjacent to the PII biosynthetic gene *snaB* ([Fig. 1](#f1){ref-type="fig"}). *samS* encodes a putative *S*‐adenosylmethionine synthetase and was shown to be involved in PI but not in PII biosynthesis ([@b7]; [@b23]).

The gene located directly downstream of *samS* encodes a deduced protein that shows similarity to an adenosine kinase. Because there is no nucleoside residue present in the pristinamycins, this adenosine kinase is most likely not involved in antibiotic biosynthesis but probably needed for purine synthesis during primary metabolism. Other genes identified on this cosmid code for primary metabolic enzymes such as methionine synthase, 5,10‐methylentetrahydrofolate reductase and *S*‐adenosyl‐[l]{.smallcaps}‐homocysteine hydrolase, which are enzymes of the folate pathway. Similarities were also found with a gene encoding a predicted ATP‐dependent DNA helicase (data not shown). Altogether, these similarities indicate that an involvement of the genes in the biosynthesis of pristinamycin is unlikely. Thus, we postulate that no further pristinamycin biosynthetic genes are located downstream of *samS*, which therefore assigns the left border of the cluster.

The right boundary was previously defined by the gene *snbR* that codes for a predicted ABC transporter protein probably involved in conferring resistance to pristinamycin ([@b7]) ([Fig. 1](#f1){ref-type="fig"}).

On cosmid pYJM2, five *orf*s of unknown function and four regulatory genes, designated as *papR3*, *papR4*, *papR5* and *spbR*, were identified in the upstream region of *snbR* ([Fig. 2](#f2){ref-type="fig"}). The orfs *papR3* and *papR5* both encode deduced proteins showing similarity to TetR repressor proteins, whereas the predicted gene product of *papR4* revealed a high degree of similarity to *Streptomyces* antibiotic regulatory proteins (SARPs). The orfs *papR3*, *papR4* and *papR5* were already shown to be involved in the regulation of pristinamycin biosynthesis (Y. Mast, unpublished results). In addition, the gene *spbR* could be identified at the right border of the cluster. It encodes a γ‐butyrolactone receptor protein, whose regulatory function was demonstrated previously but whose genetic location was so far unknown ([@b18]). SpbR acts as the global regulator of pristinamycin biosynthesis. The TetR repressor proteins PapR3 and PapR5 function as repressors of pristinamycin biosynthesis, whereas the SARP regulator PapR4, as well as PapR1 and PapR2 ([Table 1](#t1){ref-type="table"}), activates pristinamycin biosynthesis. All the regulators are part of a complex signalling cascade that is responsible for the fine‐tuned regulation of pristinamycin production (Y. Mast, unpublished results). After assigning functions to all identified genes (see below), we propose that all essential pristinamycin biosynthetic genes are identified. Thus, instead of *snbR*, *spbR* probably marks the right border of the pristinamycin gene region. However, we cannot exclude that upstream of *spbR* pristinamycin‐related genes are localized that may be involved in, but are not essential for pristinamycin biosynthesis.

PII biosynthetic genes
----------------------

Between regions C and D, 16 *orf*s (*snaF*, *snaE1*, *snaE2*, *snaG*, *snaH*, *snaI*, *snaJ*, *snaK*, *snaL*, *snaE3*, *snaE4*, *snaM*, *snaN*, *snaO*, *snaP* and *snaQ*) were identified, whose predicted gene products show ∼ 60--90% amino acid identity to gene products that are putatively involved in the virginiamycin M (VM) biosynthesis of *Streptomyces virginiae*, published by [@b35]) ([Table 1](#t1){ref-type="table"}). To date 75 kb of the *S. virginiae* gene cluster have been described harbouring 34 genes ([@b35]). Due to the structural similarity of pristinamycin and virginiamycin, we expect that the respective gene products have a similar function in both strains. However, there are also several differences between both clusters. Below, we specify some of the predicted gene products of *S. pristinaespiralis* together with their corresponding as well as missing counterparts in *S. virginiae* and their predicted functions in streptogramin type A biosynthesis.

**Genes for precursor supply.** The newly identified PII structural gene *snaF* is located downstream of the regulatory gene *papR1* and encodes a predicted protein with similarity to the branched α‐keto acid decarboxylase BkdA of *S. virginiae*. The gene *bkdA* was already shown to be essential for VM biosynthesis ([@b36]). It is part of the *bkdAB* operon, of which *bkdB* codes for a predicted dihydrolipoamide acyltransferase BkdB. BkdA and BkdB are suggested to convert valine into isobutyryl‐CoA, which serves as the primer for VM biosynthesis. In *S. pristinaespiralis*, the respective dihydrolipoamide acyltransferase is not encoded by a discrete gene but by the first ∼ 2 kb of the gene *snaE1*, which is located downstream of *snaF*. *snaE1* codes for a hybrid PKS/NRPS, and through inactivation experiments, has been shown to be essential for PII biosynthesis (Y.‐F. Bizouerne, unpublished). SnaF and the dihydrolipoamide acyltransferase domain of SnaE1 together might constitute a branched‐chain α‐keto acid dehydrogenase complex, which is responsible for supplying the isobutyryl‐CoA precursor for PII biosynthesis ([Fig. 3A](#f3){ref-type="fig"}).

**Genes encoding PKS/NRPS and tailoring enzymes.** Five genes (*snaE1*, *snaE2*, *snaE3*, *snaE4* and *snaD*) encode multifunctional enzymes such as PKS, NRPS and hybrid PKS/NRPS. *snaE1* codes for the deduced large hybrid PKS/NRPS complex SnaE1, which consists of the loading module, two PKS modules and one NRPS module. SnaE1 is probably responsible for attaching the isobutyryl‐CoA starter unit to the first acyl carrier protein (ACP) loading domain followed by the addition of two malonyl‐CoA molecules and a glycine residue. The *snaE2* gene is located directly downstream of *snaE1* and encodes the predicted PKS SnaE2 that contains two PKS modules that are responsible for the incorporation of two further malonyl‐CoA molecules ([Fig. 3A](#f3){ref-type="fig"}). SnaE1 and SnaE2 together show similarity to the predicted large PKS/NRPS complex VirA of *S. virginiae*, whose coding gene has been shown to be essential for VM biosynthesis ([@b35]). SnaE2 contains two ACP domains, and a third one is encoded by a discrete gene named *snaG*. This ACP tridomain is part of a 3‐hydroxy‐3‐methylglutaryl (HMG) enzyme cassette as found in the curacin and the jamaicamide gene cluster of *Lyngbya majuscula* ([@b20]). Such HMG enzyme cassettes catalyse β‐branching reactions in the growing polyketide. They normally consist of a tandem ACP tridomain, a ketosynthase and a HMG‐CoA synthase, which is often followed by two enoyl‐CoA hydratase enzymes. In *S. pristinaespiralis*, *snaH*, *snaI*, *snaJ* and *snaK* code for predicted monofunctional enzymes that are similar to the deduced ketosynthase‐like carboxylase VirB, to HMG‐CoA synthase‐like protein VirC and the enoyl‐CoA hydratases VirD and VirE of *S. virginiae* respectively. Due to the respective amino acid identities, the two SnaE2 ACP domains together with SnaG‐I might constitute a HMG enzyme cassette, which is followed by the two enoyl‐CoA hydratases SnaJ and K. We predict SnaH‐K to insert a methyl group at the C12 position of PII (SnaI) and to catalyse the subsequent dehydration (SnaJ) and decarboxylation (SnaK) to yield a C~11~αβ‐unsaturated thioester ([Fig. 3B](#f3){ref-type="fig"}). *snaE3* encodes a putative PKS consisting of two PKS modules that probably are needed for the addition of another two malonyl‐CoA. The N‐terminal part of SnaE3 is similar to the deduced PKS VirF, whereas the C‐terminal part corresponds to the hybrid PKS/NRPS VirG. The *snaE4* gene codes for a putative hybrid NRPS/PKS, which is similar to the deduced hybrid PKS/NRPS VirH of *S. virginiae* and which consists of an NRPS and a PKS domain. The SnaE4 NRPS is suggested to introduce a serine into the growing polyketide chain, whereas the PKS module is probably inactive because its ketosynthase domain is missing the conserved amino acid sequence pattern VDTACSSS, which is essential for activity ([@b29]). Finally, *snaD*, which has already been shown to be essential for PII biosynthesis ([@b7]), codes for the NRPS SnaD, which introduces the final residue proline into the PII precursor.

**Accessory and tailoring genes.** Twelve of the newly identified genes (*snaF*, *snaG*, *snaH*, *snaI*, *snaJ*, *snaK*, *snaL*, *snaM*, *snaN*, *snaO*, *snaP* and *snaQ*) within the pristinamycin gene region code for monofunctional polypeptides. The putative function of *snaG‐snaK* during PII biosynthesis is described above. Interestingly, in all PII PKSs (SnaE1, SnaE2, SnaE3 and SnaE4) the internal acyltransferase (AT) domains are missing. Generally, the AT domains of PKSs are responsible for the selection and loading of CoA‐activated extender units onto the ACP domains; subsequently, the ketosynthase (KS) domains finally catalyse the condensation of each extender unit, resulting in the elongation of the polyketide chain. Downstream of *snaE4*, we identified *snaM* whose deduced gene product is similar to the discrete AT VirI of *S. virginiae*. VirI is probably responsible for loading the several acyl units to the 'AT‐less' VM PKSs as first experiments indicate ([@b35]). Due to the striking similarity between SnaM and VirI ([Table 1](#t1){ref-type="table"}), we suggest that SnaM acts accordingly as a malonyl‐CoA specific iterative AT in loading the acyl precursors to the 'AT‐less'*S. pristinaespiralis* PKSs during PII biosynthesis.

Phylogenetic analyses of acyltransferase domains of *cis* and *trans*‐AT PKS gene clusters demonstrate that SnaM is a member of a clade comprised exclusively of discrete ATs of *trans*‐AT‐PKS biosynthetic gene clusters such as LnmG from leinamycin biosynthesis ([@b12]) or KirCI from kirromycin biosynthesis ([@b45]) ([Fig. 4](#f4){ref-type="fig"}). It is noteworthy that these enzymes are phylogenetically more closely related to ATs from fatty acid synthases than to the internal AT domains of *cis*‐AT PKS.

![Consensus tree of alignment of acyltransferase core domains of *cis*‐ and *trans*‐AT‐type polyketide synthases. Outgroup is FabD from *E. coli*.](mbt0004-0192-f4){#f4}

*snaL* is localized downstream of the enoyl‐CoA hydratase gene *snaK* that codes for a deduced protein with no similarity to any known protein. Furthermore, the gene *snaN* was identified encoding a predicted 4′‐phosphopantetheinyl transferase, which is similar to VirK.

**Exclusive PII‐specific genes.** One of the striking differences between the pristinamycin and virginamycin gene cluster is the presence of three PII‐specific genes --*snaA*, *snaB* and *snaC*-- within the pristinamycin biosynthetic gene region whose homologous counterparts are missing in the virginiamycin cluster. It has previously been shown that the monooxygenase subunits SnaA and SnaB, together with the FMN reductase SnaC, are responsible for the conversion of the precursor PII~B~ to the final product PII~A~ ([@b8]) ([Fig. 3A](#f3){ref-type="fig"}). Together, these three enzymes catalyse the oxidation of the [d]{.smallcaps}‐proline residue in PII~B~ that leads to the formation of the unique dehydroproline residue in PII~A~. Because no homologous *snaA*, *snaB* and *snaC* genes were yet identified in the virginiamycin producer, the genes *virM* and *virN* that code for a predicted sarcosine oxidase VirM and a flavin‐dependent oxidoreductase VirN, respectively, were suggested to catalyse the analogous reaction in *S. virginiae*, whereby VM~2~ is converted into VM~1~ ([@b35]). However, homologues (*snaO* and *snaQ*) are also present in *S. pristinaespiralis*, suggesting that the sarcosine oxidases and flavin‐dependent oxidoreductases have a different function during streptogramin biosynthesis that so far remains unknown.

A further discrepancy between both streptogramin producers is based on the gene *snaD*. In *S. pristinaespiralis*, *snaD* codes for the peptide synthetase SnaD, which introduces a proline residue into the PII framework ([Fig. 3A](#f3){ref-type="fig"}). Proline is also a constituent of VM; however, no *snaD* homologous gene has been identified in *S. virginiae* so far. Sequence analysis revealed that SnaD contains a C‐terminal type I thioesterase (TE) domain (Y.‐F. Bizouerne, unpublished) that probably catalyses the release of the polyketide chain and the cyclization reaction resulting in the macrolactonic ring structure of PII. Since no *snaD* counterpart was found in *S. virginiae*, the final cyclization reaction was suggested to be catalysed by the predicted TE VirJ. However, also in *S. pristinaespiralis* a discrete gene, *snaP*, is present that encodes a predicted type II TE that is similar to VirJ. As type II TEs often have editing function during antibiotic biosyntheses ([@b21]; [@b41]), we propose that SnaP has a corrective function during PII biosynthesis for instance by removing aberrant acyl residues from the PII PKSs and regenerating misprimed NRPS.

PI biosynthetic genes
---------------------

The PI biosynthesis is catalysed by an NRPS system composed of three proteins, SnbA, SnbC and SnbDE. SnbA activates the starter molecule 3‐hydroxypicolinic acid, SnbC incorporates [l]{.smallcaps}‐threonine and [l]{.smallcaps}‐aminobutyric acid, and SnbDE adds [l]{.smallcaps}‐proline, DMAPA, 4‐oxo‐[l]{.smallcaps}‐pipecolic acid and [l]{.smallcaps}‐phenylglycine to the precursor molecule ([Fig. 5](#f5){ref-type="fig"}) ([@b43]). The linear precursor is then cyclized to the final PI macrocycle under release from the synthetase.

Twelve genes are involved in the PI precursor supply: *hpaA* is required for 3‐hydroxypicolinic acid formation ([@b9]), *pipA* and *snbF* are involved in the biosynthesis of 4‐oxo‐[l]{.smallcaps}‐pipecolic acid ([@b9]), and the cluster of *pap* genes code for a DMAPA biosynthetic pathway starting from chorismic acid ([Table 1](#t1){ref-type="table"}) ([@b10]). Furthermore, we identified a set of genes, designated as *pglA*, *pglB*, *pglC*, *pglD* and *pglE*, which show high amino acid identity to enzymes involved in the biosynthesis of aproteinogenic amino acids such as 4‐hydroxyphenylglycine and 3,5‐dihydroxyphenylglycine. The *pgl* genes have been shown to be responsible for the formation of [l]{.smallcaps}‐phenylglycine, which probably starts from phenylpyruvate, a compound from the primary metabolic shikimate pathway, which is converted to [l]{.smallcaps}‐phenylglycine via a phenylacetyl‐CoA intermediate (Y. Mast, unpublished). To date, no *pap* and *pgl* homologous genes have been found in the virginiamycin cluster. Together with the identification of the phenylglycine biosynthetic genes, all genes have likely been identified that are essential for pristinamycin biosynthesis.

Genes with similarity to actinorhodin‐like biosynthetic genes
-------------------------------------------------------------

Between regions B and C ([Fig. 1](#f1){ref-type="fig"}), numerous *orf*s (*cpp1‐cpp23*) were identified whose deduced gene products exhibit similarities to proteins involved in aromatic polyketide biosyntheses, such as the biosynthesis of granaticin (*gra*) of *S. violaceoruber*, actinorhodin (*act*) of *S. coelicolor* A3(2) and mithramycin (*mtm*) of *S. argillaceus* that belong to the class of benzoisochromanequinones (BIQs) ([Table 2](#t2){ref-type="table"}). The *orfs* were designated as *cpp* for 'cryptic pristinaespiralis polyketide'.

The genes *cpp19 cpp18*, *cpp17*, *cpp16* and *cpp15* presumably encode a minimal type II PKS (AT, KS, chain length‐determining factor and ACP) as their deduced gene products show similarity to minimal PKSs of the *S. coelicolor* A3(2) *act* and *S. violaceoruber gra* cluster. The genes *cpp21*, *cpp22*, *cpp13* and *cpp12* presumably code for early biosynthetic enzymes that are normally closely associated with the minimal PKS. Their deduced gene products are similar to early granaticin biosynthetic enzymes of *S. violaceoruber*. The predicted gene products of *cpp21* and *cpp22* show high amino acid identity to the ketoreductases (KR) Gra‐orf6 (80%) and Gra‐orf5 (85%) respectively, whereas *cpp13* and *cpp12* encode a deduced aromatase and a cyclase similar to Gra‐orf4 and Gra‐orf33 respectively. In the *act* mutant *S. coelicolor* CH999, the expression of an *act* gene set encoding for the minimal PKS, KR, aromatase (ARO) and cyclase (CYC) resulted in the formation of aloesaponarin II, which is a three‐ring aromatic aglycon ([@b30]). Thus, a similar compound might be the intermediate generated by the action of the homologous enzyme set in *S. pristinaespiralis*. This is also supported by the observation that the cyclases Cpp13 and Cpp12 belong to a family of cyclases involved in BIQ biosyntheses ([@b19]). Furthermore, several *orf*s were identified, whose predicted proteins presumably are involved in tailoring reactions. For instance the deduced gene products of *cpp25* and *cpp24* show high amino acid identity to the dTDP‐glucose 4,6‐dehydratase MtmE (85%) and the dTDP‐glucose synthase MtmD (89%) of *S. argillaceus*, respectively, and thus might be involved in the formation of 6‐deoxyhexose ([@b28]). The predicted gene products of *cpp14*, *cpp27*, *cpp29* and *cpp32* show similarity to several enzymes putatively involved in sugar synthesis and glycosyltransferase reactions during granaticin biosynthesis in *S. violaceoruber*. Therefore, we predict the unknown compound to have a granaticin/actinorhodin‐like skeleton and to be modified several times by glycosylation. Furthermore, *cpp1* was identified, which codes for a deduced gene similar to regulators belonging to the SARP family and thus might be responsible for regulating the biosynthesis of the unknown compound. Altogether, the cryptic PKS II gene cluster of *S. pristinaespiralis* Pr11 covers a region of approximately 40 kb ([Table 2](#t2){ref-type="table"}). However, no actinorhodin‐like compound could be detected in *S. pristinaespiralis* cultures by high‐performance liquid chromatography (HPLC), suggesting that the interjacent gene cluster is not expressed under typical pristinamycin production conditions.

To prove that the *orf*s are not required for pristinamycin biosynthesis, some representative genes (*cpp27*, *cpp7*, *cpp1*2, *cpp8* and *cpp1*) were inactivated by gene insertion mutagenesis using plasmids pJcpp27apr, pJcpp7apr, pJcpp12apr, pJcpp8apr and pJcpp1apr respectively (see *Experimental procedures*). The genotypes of the generated mutants M*cpp27*, M*cpp7*, M*cpp12*, M*cpp8* and M*cpp1*, respectively, were proven by Southern hybridization (data not shown), and antibiotic production of the mutants was analysed by HPLC. Inactivation of any of these genes had no effect on pristinamycin biosynthesis ([Fig. 6](#f6){ref-type="fig"}), suggesting that the genes lying in the interjacent PKS cluster are not involved in pristinamycin production. However, it would be interesting to find out if there is a co‐regulation between pristinamycin biosynthesis and the biosynthesis of the unknown substance maybe signalled via the SARP Cpp1, which could be a regulator interacting with the components of the pristinamycin signalling cascade.

Characteristics of the pristinamycin gene region
------------------------------------------------

A characteristic feature of the pristinamycin biosynthetic gene region is that the PI and PII biosynthetic genes that encode the synthesis of two chemically distinct components are not clustered individually but are scattered across the complete 210 kb sequence region. This special genetic organization is suggested to be the result of evolutionary chromosomal rearrangement that could somehow be beneficial for the strain ensuring the production of both antibiotics in the synergistically active 70:30 ratio ([@b4]). However, so far there has been no indication of such an evolutionary rearrangement process.

In the course of the sequence analyses, we identified a transposase gene *trs2* between the PII monooxygenase subunit genes *snaA* and *snaB* as well as approximately 7 kb upstream of *samS* near the left border of the pristinamycin biosynthetic gene region (*trs1*; [Fig. 2](#f2){ref-type="fig"}). A further transposase gene *trs3* is localized to the right site of the PKS II type biosynthetic cluster between *cpp3* and *cpp4* ([Table 2](#t2){ref-type="table"}). The presence of transposase genes within and nearby the pristinamycin biosynthetic gene region strongly suggests that the original individual clusters have been shuffled during genomic rearrangement processes.

By alignment of protein sequences, we found that the putative Trs2 and Trs3 proteins show 67% amino acid identity to each other, whereas Trs1 shows no similarity to any of the transposases found in the pristinamycin biosynthetic gene region. Thus, *trs3*, which is localized to the *cpp* gene cluster, might be a duplicate of *trs2*, encoding the transposase that might have been responsible for the insertion of the type II PKS gene cluster.

In contrast, no such transposase genes have been reported for the virginiamycin cluster. Thus, there is no hint of a horizontal gene transfer event of the streptogramin antibiotic cluster in *S. virginiae*. However, so far, the virginiamycin biosynthetic gene cluster only comprises 75 kb and as some essential virginiamycin biosynthetic genes have not been identified, it seems that the cluster is still incomplete. Thus, it might be possible that there are transposase genes present in the entire cluster, which have not yet been identified ([Fig. 7](#f7){ref-type="fig"}). In this context, it would be interesting to find out how the streptogramin biosynthetic gene clusters evolved. The high amino acid identity between numerous pristinamycin and virginiamycin specific proteins indicates that both clusters may originate from a common ancestor. Probably, a primordial actinomycete originally produced only one type of streptogramin antibiotic and the second cluster was acquired by horizontal gene transfer. To date, no strain is known that produces only one type of streptogramin. It would be interesting to identify such a strain to get more information about which cluster was acquired at first.

![Comparison between the pristinamycin biosynthetic gene region and the virginiamycin cluster. Homologous genes are presented as coloured arrows: genes with similar orientations in both clusters are labelled turquoise; genes with different orientations are labelled orange and connected by lines due to their respective homologies. Genes with no homologous counterpart in the respective cluster are labelled black.](mbt0004-0192-f7){#f7}

A unique feature of the pristinamycin biosynthetic gene region is that it is interrupted by a cryptic type II PKS gene cluster. Probably also this cluster has been acquired by horizontal gene transfer. In *S. pristinaespiralis*, the type II PKS gene cluster is localized between the response regulator gene *papR6* and the gene *snaQ* encoding the putative flavin‐dependent oxidoreductase. In the virginiamycin cluster, the homologous counterparts of these genes are present (*vmsT* and *virN* respectively); however, there is no further cluster inserted at this position. Thus, we suggest the pristinamycin biosynthetic gene region with its integrated *cpp* cluster is of later evolutionary origin than the virginiamycin biosynthetic gene region. To our knowledge, no other streptogramin antibiotic gene cluster contains such an intercalary secondary metabolite biosynthetic gene cluster. Altogether, this makes the pristinamycin biosynthetic gene region the largest antibiotic 'supercluster' with a size of ∼ 210 kb harbouring genes for at least three different antibiotic biosynthesis pathways.

The advantage of such a supercluster organization could be to ensure the co‐regulation and thus co‐production of different small molecules, which could be beneficial for the producer strain as mentioned above. Evidence for the co‐regulation of the different pristinamycins includes the fact that the *S. pristinaespiralis* global regulator SpbR and several other regulators influence the biosynthesis of both compounds: PI and PII. For example, deletion of *spbR* leads to no pristinamycin production at all ([@b18]), whereas the overexpression of any of the pristinamycin SARP regulators results in enhanced PI as well as PII biosynthesis (Y. Mast, unpublished). Further examples of co‐regulation were reported for *S. virginiae*, of which a VM biosynthetic gene and a virginiamycin S resistance gene are under the control of the same regulator ([@b32]). Also the lankamycin and lankacidin productions of *Streptomyces rochei* are influenced by the same regulator ([@b31]). A well‐understood system is the co‐regulation of the production of the β‐lactam antibiotic cephamycin and the β‐lactamase inhibitor clavulanic acid in *Streptomyces clavuligerus*, where the biosynthetic genes are organized in a concatenate supercluster and are regulated by the same transcriptional activator protein CcaR ([@b40]). However, there are some reports that claim that co‐regulation is not the driving force for clustering of secondary metabolite genes ([@b27]; [@b44]).

But then the question arises why those different antibiotic biosynthetic genes are all mixed up in one large cluster. In general, antibiotic genes tend to cluster in the genome of their microbial producers. These antibiotic gene clusters are 'selfish genetic elements' that evolve rapidly ([@b17]). The 'selfish cluster' hypothesis says that clustering, in the first place, does not have a selective advantage for the donor organism, but confers a new selective advantage to the unsophisticated recipient genome ([@b27]; [@b44]). In this context, the existence of clusters is beneficial because horizontal gene transfer requires the movement of contiguous DNA fragments, and clustering ensures that all essential genes needed for biosynthesis, regulation and resistance of the respective antibiotics can be transferred together to a recipient. The pristinamycin biosynthetic gene region would be one of the best examples for the 'selfish cluster hypothesis'.

Experimental procedures
=======================

Bacterial strains, cosmids and plasmids
---------------------------------------

The bacterial strains, cosmids and plasmids used in this study are listed in Table S1.

Media and culture conditions
----------------------------

*Escherichia coli* XL1‐Blue ([@b11]) was used as the host for subcloning. *Escherichia coli* strains were grown in Luria--Bertani (LB) medium at 37°C ([@b39]) supplemented with kanamycin, apramycin or ampicillin (50, 100 or 150 µg ml^−1^ respectively) when appropriate.

*Streptomyces pristinaespiralis* Pr11 (Aventis Pharma) was used throughout this study. This strain was isolated after spontaneous mutation of *S. pristinaespiralis* ATCC 25486. *Streptomyces pristinaespiralis* Pr11 was used for cosmid library construction and for the generation of gene insertion mutants. *Streptomyces pristinaespiralis* strains were grown on yeast malt agar or on MS agar for isolation of spores ([@b26]). For isolation of genomic DNA *S. pristinaespiralis* strains were grown in 100 ml of S‐medium ([@b26]) in 500 ml Erlenmeyer flasks (with steel springs) on an orbital shaker (180 r.p.m.) at 30°C. Liquid cultures were supplemented with kanamycin or apramycin (50 or 100 µg ml^−1^ respectively) when appropriate.

Cloning, restriction mapping and *in vitro* manipulation of DNA
---------------------------------------------------------------

The methods used for the isolation and manipulation of DNA from *S. pristinaespiralis* and *E. coli* were as described by [@b26]) and [@b39]) respectively. Polymerase chain reactions were performed on a RoboCycler Gradient 40 thermocycler from Stratagene (La Jolla, CA, USA) or on a Primus 96^plus^ (MWG Biotech) using *Taq* DNA polymerase (QIAGEN). Primers used for PCR are listed in Table S2. PCR fragments were isolated from 1% agarose gels and purified with GE Healthcare GFX columns. Isolation of *Streptomyces* genomic DNA was performed with the NucleoSpin Tissue Kit (Macherey‐Nagel). Restriction endonucleases were obtained from various suppliers and were used according to their specifications. *Escherichia coli* was transformed by the CaCl~2~ method ([@b39]). Plasmids were introduced into *Streptomyces* strains by polyethylene glycol‐mediated protoplast transformation ([@b26]).

Construction and screening of a cosmid library
----------------------------------------------

A cosmid library of *S. pristinaespiralis* Pr11 DNA was constructed by Combinature Biopharm AG using cosmid pOJ436 ([@b6]). The cosmids were automatically spotted on a nylon membrane. This filter was used in hybridization experiments to identify cosmids that overlap with already published or patented sequences ([@b7]; [@b4]). Southern hybridizations with the digoxygenin DNA labelling and detection kit from Roche Biochemicals were carried out as described previously ([@b33]).

DNA fragments covering the gaps and borders of the pristinamycin biosynthetic gene region
-----------------------------------------------------------------------------------------

The probes *frgBR*, *frgCL*, *frgCR* and *frgDL* were used to close the large gaps between region B, C and D. *frgBR* and *frgCR* hybridized with the right borders of regions C and B respectively, whereas probe *frgCL* and *frgDL* hybridized with the left border of regions C and D respectively ([Fig. 1](#f1){ref-type="fig"}). The probes were used for screening the *S. pristinaespiralis* cosmid library. Altogether, 31 cosmids were isolated that overlapped with the ends of known cosmids, thus spanning the gaps from region B to C and C to D respectively. The cosmids were analysed in restriction, PCR and Southern blot experiments. Cosmid pYJM3, pYJM4 and pYJM5 showed minimal overlap with already known sequences and carried a large portion of new sequence data. Cosmid pYJM3 and pYJM4 span the gap between regions B and C, whereas pYJM5 covers the gap between regions C and D ([Fig. 1](#f1){ref-type="fig"}).

The probes *frgsamS* and *frgsnbR* were used to find the left and right boundaries of the pristinamycin biosynthetic gene region respectively. The probes were used for screening the *S. pristinaespiralis* cosmid library. Twenty‐seven cosmids were isolated that hybridized with the *frgsamS* probe, thus overlapping the left border of the pristinamycin gene region, whereas 31 cosmids were isolated that hybridized with the *frgsnbR* probe, characterizing the right border of the cluster. Two cosmids were chosen to be sequenced: cosmid pYJM1 and pYJM2 that overlap with the left and right boundaries of the pristinamycin biosynthetic gene region respectively ([Fig. 1](#f1){ref-type="fig"}).

DNA sequencing and analysis
---------------------------

DNA sequencing of cosmids pYJM1‐5 was performed by shotgun cloning followed by automated DNA sequencing carried out on double‐stranded DNA templates to obtain at least fourfold coverage. Sequencing was done by GATC, MWG, or Göttingen Genomics Laboratory (G2L) respectively, and the obtained raw sequence data were assembled using phred/phrap/consed and analysed with [clusean]{.smallcaps} ([@b46]), [blast]{.smallcaps} ([@b3]) and Artemis ([@b38]). The sequences were deposited in the EMBL data library under accession numbers FR681999, FR682000 and FR682001.

Phylogenetic analysis
---------------------

Acyltransferase domains were identified using the Pfam 'Acyl_transf' HMM Profile, extracted and aligned using muscle ([@b15]). Prior to tree reconstruction, the alignment was manually edited. Trees were calculated using Splitstree 4.2 ([@b24]). Parameters were determined using Prottest ([@b1]): WAG+I+G model; *P*~inv~ = 0.02; α = 1.32. Tree reconstruction was performed using Neighbor Joining with 1000 bootstrap replicates. The majority consensus method was used to calculate the consensus tree in Dendroscope ([@b25]).

Gene insertion mutagenesis of cpp genes
---------------------------------------

Internal fragments of the genes *cpp27* (∼ 0.9 kb), *cpp7* (∼ 0.8 kb), *cpp12* (∼ 0.8 kb) and *cpp8* (∼ 1.1 kb) were amplified by PCR using *S. pristinaespiralis* genomic DNA as a template and the primer pairs Pcpp27m1/m2, Pcpp7m1/m2, Pcpp12m1/m2 and Pcpp8m1/m2 respectively. The amplified fragments were designated cpp27\*, cpp7\*, cpp12\* and cpp8\* respectively. Fragments cpp27\* and cpp8\* were subcloned in EcoRV‐restricted *E. coli* vector pJOE890 resulting in the constructs pJOE890/cpp27\* and pJOE890/cpp8\* respectively, whereas fragments cpp7\* and cpp12\* were subcloned in EcoRV‐restricted *E. coli* vector pDrive, resulting in the constructs pDrive/cpp7\* and pDrive/cpp12\* respectively. Subsequently, a 1.5 kb *aac(3)IV* cassette was isolated as an EcoRV/SmaI fragment from pEH13 and cloned into the singular ScaI restriction site of pJOE890/cpp27\* and pJOE890/cpp8\*, respectively, resulting in the constructs pJOE890/cpp27\*apr and pJOE890/cpp8\*apr, as well as into the singular ScaI restriction site of pDrive/cpp7\* and pDrive/cpp12\*, resulting in the constructs pDrive/cpp7\*apr and pDrive/cpp12\*apr. For the construction of Mcpp1, a ∼ 2.5 kb fragment (cpp1\*) was amplified by PCR, using *S. pristinaespiralis* genomic DNA as a template and the primer pairs Pcpp1m1/m2, which encompasses the entire *cpp1* gene, 0.5 kb of the *cpp1*‐upstream and 0.8 kb of the *cpp1*‐downstream region. cpp1\* was subcloned in EcoRV‐restricted *E. coli* vector pJOE890 resulting in construct pJOE890/cpp1\*. Subsequently, a 1.5 kb *aac(3)IV* cassette was isolated as an EcoRV/SmaI fragment from pEH13 and cloned into the singular StuI restriction site within the *cpp1* gene of pJOE890/cpp1\* resulting in construct pJOE890/cpp1\*apr.

The targeting plasmids pJOE890/cpp27\*apr, pJOE890/cpp8\*apr, pDrive/cpp7\*apr, pDrive/cpp12\*apr and pJOE890/cpp1\*apr were transferred into *S. pristinaespiralis* Pr11 by protoplast transformation ([@b26]). Apramycin‐resistant, kanamycin‐sensitive transformants were analysed with PCR and/or Southern hybridization experiments (data not shown) to identify those clones in which a double‐cross‐over event between the chromosomal copy of *cpp27*, *cpp7*, *cpp12*, *cpp8* and *cpp1* and the mutated fragment located on pJOE890/cpp27\*apr, pJOE890/cpp8\*apr, pDrive/cpp7\*apr, pDrive/cpp12\*apr and pJOE890/cpp1\*apr, respectively, had occurred.

Pristinamycin production conditions and detection
-------------------------------------------------

For pristinamycin production, strains were cultivated in 100 ml inoculum medium consisting of corn steep powder (10 g l^−1^), saccharose (15 g l^−1^), (NH~4~)~2~SO~4~ (10 g l^−1^), K~2~HPO~4~ (1 g l^−1^), NaCl (3 g l^−1^), MgSO~4~ × 7H~2~O (0.2 g l^−1^), CaCO~3~ (1.25 g l^−1^) and tap water. The pH was adjusted to 6.9 prior to CaCO~3~ addition and sterilization. Cultures were incubated at 30°C in 100 ml of inoculum medium in 500 ml Erlenmeyer flasks (with steel springs) on an orbital shaker (180 r.p.m.). After 48--72 h, 17 ml of precultures was inoculated in 200 ml of production medium consisting of soybean flour (25 g l^−1^), starch (7.5 g l^−1^), glucose (22.5 g l^−1^), yeast extract (3.5 g l^−1^), ZnSO~4~ × 7H~2~O (0.5 g l^−1^), CaCO~3~ (6 g l^−1^) and tap water. The pH was adjusted to 6.0 prior to CaCO~3~ addition and sterilization. Production cultures were cultivated for 3--4 days at 30°C in 1 l Erlenmeyer flasks with steel springs on an orbital shaker (180 r.p.m.). Five millilitres of *S. pristinaespiralis* cultures was extracted with 5 ml ethyl acetate for 20 min and concentrated completely in vacuo. The extract was then redissolved in appropriate volumes of propan‐2‐ol (0.75 ml for 5 ml extraction volume), and samples were analysed by HPLC and diode‐array detection ([@b16]). HPLC analyses were performed on an HP1090M/HP3392A/HP7994B system (Hewlett Packard) with Nucleosil C18 columns (5 µm, 125 mm × 4.6 mm) (Grom) with a flow rate of 2 ml min^−1^. The following linear gradient for elution was applied using solvent PhoA (100% water with 0.1% phosphoric acid) and solvent AcCN (100% acetonitrile): at 0 min: 100% PhoA; at 15 min: 100% AcCN; at 16 min: PhoA, at 21 min: PhoA. Pristinamycin was detected at wavelength l = 230 nm and compared with a purified substance (provided by Sanofi‐Aventis) and to an HPLC‐UV/Vis spectra library ([@b16]).
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